Alnylam Pharmaceuticals, Inc. · NASDAQ:ALNY

Capital Research Global Investors reported a 5.40% stake in Alnylam Pharmaceuticals, Inc. (Schedule 13G)

Event Dec 31, 2024 · Filed Feb 13, 2025

Capital Research Global Investors reported a 5.40% stake in Alnylam Pharmaceuticals, Inc., 6,968,513 shares, as a passive investor on Dec 31, 2024. Filed Feb 13, 2025 (Schedule 13G).

Stake
5.40%
Shares
6,968,513
Intent
Passive
What changed
Crossed above 5%

The filing in full

HolderStakeShares
Capital Research Global Investors5.40%6,968,513

Source

View original at SEC

Related